Unichem Labs’ Kolhapur Plant Clears USFDA Inspection with No Data Integrity Issues

Unichem Laboratories has successfully concluded a USFDA inspection at its Kolhapur manufacturing facility, with the regulator issuing only five observations and no findings related to data integrity — a critical benchmark for global regulatory compliance. The absence of data integrity issues underscores the facility’s adherence to quality standards and reduces risk of import alerts or market restrictions. While the five observations require corrective actions, they are considered minor and do not impact ongoing operations or product approvals. This positive outcome reinforces Unichem’s ability to maintain compliance in key international markets and supports uninterrupted supply of generic drugs from the Kolhapur plant to both domestic and overseas customers.